One-year outcomes of the Cardioband TR early feasibility study for functional tricuspid regurgitation
Presenter:
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Grant Support/Research Contract (Both) - Conformal
- Consultant Fee/Honoraria/Speaker's Bureau (Both) - Shockwave; Medtronic; Philips; Contego Medical
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - W.L. Gore & Associates
- Industry Salary/Salary Support/Employee (full time or part time) (Both) - Boston Scientific Corporation
- Grant Support/Research Contract (Institutional) - Edwards Lifesciences